[Panic disorder and agoraphobia in general practice: Advantages and pitfalls of a practice team-supported exposure training from the general practitioner's perspective - a qualitative study].

Panikstörung und Agoraphobie hausärztlich behandelt: Vorzüge und Fallstricke eines Praxisteam-unterstützten Expositionstrainings aus Sicht von Hausärztinnen und Hausärzten – eine qualitative Studie.
Allgemeinmedizin Angststörungen CBT Case Management KVT Prozessevaluation anxiety disorders case management family practice process evaluation

Journal

Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen
ISSN: 2212-0289
Titre abrégé: Z Evid Fortbild Qual Gesundhwes
Pays: Netherlands
ID NLM: 101477604

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 07 12 2018
revised: 02 05 2019
accepted: 03 05 2019
pubmed: 10 6 2019
medline: 17 9 2019
entrez: 10 6 2019
Statut: ppublish

Résumé

For the treatment of anxiety disorders behavior therapy-oriented methods are recommended for primary care as well. Within the trial "Jena-PARADISE" a primary care practice team-supported exposure training for patients with panic disorder with or without agoraphobia was developed and evaluated. The present paper gives an overview of general practitioners' subjective views on the practicability, feasibility and effectiveness of this new intervention for both patients and GP teams. Questions were operationalized based on Bellg's intervention fidelity framework. Fourteen GPs of the intervention group were sampled purposefully and interviewed in a semi-structured way. Generated data were analyzed following Mayring's content analysis approach. The treatment program was positively assessed among the GPs and seen as a useful therapeutic option for inadequately treated patients. The therapy elements 'psycho-education' and 'interoceptive exposure exercises' were described as feasible, while situational exercises and relapse prevention got a less positive rating. The active participation of the nurse in the treatment program was seen as supportive. From the GP perspective, the treatment program for patients with panic disorder and/or agoraphobia seems to be a viable therapeutic option in primary care.

Identifiants

pubmed: 31176641
pii: S1865-9217(19)30049-2
doi: 10.1016/j.zefq.2019.05.002
pii:
doi:

Types de publication

Journal Article

Langues

ger

Sous-ensembles de citation

IM

Pagination

15-20

Informations de copyright

Copyright © 2019. Published by Elsevier GmbH.

Auteurs

Jörg Breitbart (J)

Institut für Allgemeinmedizin, Universitätsklinikum Jena, Jena, Deutschland.

Thomas Stephan Hiller (TS)

Institut für Allgemeinmedizin, Universitätsklinikum Jena, Jena, Deutschland.

Elisabeth Schöne (E)

Institut für Allgemeinmedizin, Universitätsklinikum Jena, Jena, Deutschland.

Mercedes Schelle (M)

Institut für Allgemeinmedizin, Universitätsklinikum Jena, Jena, Deutschland.

Ulf Sauerbrey (U)

Institut für Allgemeinmedizin, Universitätsklinikum Jena, Jena, Deutschland.

Michael Sommer (M)

Institut für Allgemeinmedizin, Universitätsklinikum Jena, Jena, Deutschland.

Wolfgang Blank (W)

Institut für Allgemeinmedizin, Universitätsklinikum Jena, Jena, Deutschland.

Sven Schulz (S)

Institut für Allgemeinmedizin, Universitätsklinikum Jena, Jena, Deutschland.

Horst Christian Vollmar (HC)

Abteilung für Allgemeinmedizin, Fakultät für Medizin, Ruhr-Universität Bochum, Bochum, Deutschland; Institut für Allgemeinmedizin, Universitätsklinikum Jena, Jena, Deutschland.

Michel Wensing (M)

Abteilung Allgemeinmedizin und Versorgungsforschung, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.

Jürgen Margraf (J)

Forschungs- und Behandlungszentrum für psychische Gesundheit, Ruhr-Universität Bochum, Bochum, Deutschland.

Jochen Gensichen (J)

Institut für Allgemeinmedizin, Klinikum der Universität München, München, Deutschland; Institut für Allgemeinmedizin, Universitätsklinikum Jena, Jena, Deutschland. Electronic address: Jochen.Gensichen@med.uni-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH